NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/05/2017
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
Stephen J. Mayfield York Howell & Guymon
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
anti-diabetic pharmaceuticals, cardiovascular pharmaceuticals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, ocular pharmaceuticals, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of macular degeneration, corneal neovascularization, diabetic retinopathy, cancer, stroke, heart disease, wound healing; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical products for opthalmological use, plant extracts for medical, veterinary and pharmaceutical purposes
History of USPTO decisions and trademark events.
37 publications found
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/05/2017
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/05/2017
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/05/2017
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/23/2017
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
01/09/2017
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2017
TEAS SECTION 8 & 9 RECEIVED
10/28/2016
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/25/2016
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2015
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/10/2015
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/23/2013
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/22/2013
REGISTERED - SEC. 8 (6-YR) FILED
08/22/2013
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/20/2013
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
06/13/2013
REGISTERED - SEC. 15 ACKNOWLEDGED
06/13/2013
POST REGISTRATION ACTION MAILED - SEC. 8
06/13/2013
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2013
TEAS SECTION 15 RECEIVED
06/12/2013
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/12/2013
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/07/2013
TEAS SECTION 8 RECEIVED
06/07/2013
REGISTERED-PRINCIPAL REGISTER
09/25/2007
LAW OFFICE REGISTRATION REVIEW COMPLETED
08/22/2007
ASSIGNED TO LIE
08/22/2007
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/11/2007
STATEMENT OF USE PROCESSING COMPLETE
07/10/2007
USE AMENDMENT FILED
04/09/2007
TEAS STATEMENT OF USE RECEIVED
04/09/2007
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/10/2006
PUBLISHED FOR OPPOSITION
07/18/2006
NOTICE OF PUBLICATION
06/28/2006
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/02/2006
ASSIGNED TO LIE
05/19/2006
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2006
ASSIGNED TO EXAMINER
05/10/2006
NEW APPLICATION ENTERED
11/09/2005
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.